FDA Releases Draft Guidance for Labeling Over-the-Counter Human Drug Products

Summary

The Food and Drug Administration (FDA) has made available a draft guidance document aimed at helping manufacturers of over-the-counter (OTC) human drugs comply with the agency's labeling regulations, which apply to products marketed under abbreviated new drug applications (ANDA's) and reference listed drugs (RLD's).